Xvivo Perfusion
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar! XVIVO’s CEO to present at J.P. Morgan’s 44th Annual Healthcare Conference in San Francisco
Today, XVIVO announced its participation in the 44th annual J.P. Morgan Healthcare Conference in San Francisco, US, on Wednesday, January 14, 2026. Christoffer Rosenblad, CEO, was invited to deliver a formal presentation and participate in a Q&A session beginning at 4:30 p.m. PST.
Rosenblad’s presentation will focus on the future of the organ transplant industry and how new technologies are expanding access to donated organs and increasing overall organ utilization. He will specifically discuss the evolving paradigm of heart preservation, using the XVIVO Heart Assist Transport™, which is currently undergoing clinical trials in the United States, as an example.
Rosenblad’s remarks will be webcast simultaneously here:
https://jpmorgan.metameetings.net/events/healthcare26/sessions/317413-xvivo-perfusion-ab/webcast?gpu_only=true&kiosk=true
A replay of the webcast will be archived on XVIVO’s website for 30 days following the presentation.
Molndal, Sweden
January 6, 2026
XVIVO
| Datum | 2026-01-06, kl 14:45 |
| Källa | MFN |